Education
About Us
Working with TipRanks
Follow Us
AlzChem Group AG (DE:ACT)
XETRA:ACT
Earnings Data
Report Date
Feb 27, 2026TBA (Not Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
1.49Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in the Specialty Chemicals segment and successful strategic partnerships, with overall positive financial performance and significant investments in future growth. However, challenges remain in the Basics & Intermediates segment and due to high electricity costs.Company Guidance
Specialty Chemicals Segment Growth
The Specialty Chemicals segment recorded a 9% increase in sales, driving overall growth. EBITDA for this segment increased by 16%, with a margin improvement to almost 28%.
EBITDA and Margin Improvement
EBITDA grew by 12% to EUR 86 million, with the margin increasing from 18.5% to 20.3%, attributed to positive developments in Specialty Chemicals.
Creatine Expansion and Cooperation with Ehrmann
An expansion of creatine production was successfully commissioned, and a notable cooperation with Ehrmann for high-protein creatine products was launched.
CapEx Activities and New Plant Developments
Construction of new plants is on schedule and budget, with significant CapEx investments supporting future growth.
Positive Group Net Result
The group net result increased by 20% to EUR 45 million, with earnings per share rising to EUR 4.62.
DE:ACT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:ACT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | €149.20 | €162.00 | +8.58% |
Jul 30, 2025 | €146.00 | €135.20 | -7.40% |
Apr 30, 2025 | €105.11 | €111.42 | +6.00% |
Feb 28, 2025 | €72.57 | €76.91 | +5.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AlzChem Group AG (DE:ACT) report earnings?
AlzChem Group AG (DE:ACT) is schdueled to report earning on Feb 27, 2026, TBA (Not Confirmed).
What is AlzChem Group AG (DE:ACT) earnings time?
AlzChem Group AG (DE:ACT) earnings time is at Feb 27, 2026, TBA (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of AlzChem Group AG stock?
The P/E ratio of AlzChem Group AG is N/A.
What is DE:ACT EPS forecast?
Currently, no data Available